These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 2425647)

  • 1. Development of a sporozoite malaria vaccine.
    Nussenzweig V; Nussenzweig RS
    Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647
    [No Abstract]   [Full Text] [Related]  

  • 2. The malaria sporozoite vaccine: parasitology's brave new world.
    Spriggs DR
    J Infect Dis; 1985 Sep; 152(3):655-6. PubMed ID: 2411830
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malaria vaccine research].
    Sellioğlu B
    Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host immune response and pathological expression in malaria: possible implications for malaria vaccines.
    Grau GE; Del Giudice G; Lambert PH
    Parasitology; 1987; 94 Suppl():S123-37. PubMed ID: 2438630
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.
    Young JF; Hockmeyer WT; Gross M; Ballou WR; Wirtz RA; Trosper JH; Beaudoin RL; Hollingdale MR; Miller LH; Diggs CL
    Science; 1985 May; 228(4702):958-62. PubMed ID: 2988125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review.
    Heidrich HG
    Z Parasitenkd; 1986; 72(1):1-11. PubMed ID: 3515789
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent efforts in the development of a sporozoite vaccine against human malaria.
    Hockmeyer WT; Dame JB
    Adv Exp Med Biol; 1985; 185():233-45. PubMed ID: 3907309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trials.
    Caspers P; Gentz R; Matile H; Pink JR; Sinigaglia F
    Mol Biochem Parasitol; 1989 Jun; 35(2):185-9. PubMed ID: 2671723
    [No Abstract]   [Full Text] [Related]  

  • 10. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.
    Kabilan L; Troye-Blomberg M; Perlmann H; Andersson G; Högh B; Petersen E; Björkman A; Perlmann P
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5659-63. PubMed ID: 2456577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.
    Egan JE; Weber JL; Ballou WR; Hollingdale MR; Majarian WR; Gordon DM; Maloy WL; Hoffman SL; Wirtz RA; Schneider I
    Science; 1987 Apr; 236(4800):453-6. PubMed ID: 3551073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
    Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei.
    Romero PJ; Tam JP; Schlesinger D; Clavijo P; Gibson H; Barr PJ; Nussenzweig RS; Nussenzweig V; Zavala F
    Eur J Immunol; 1988 Dec; 18(12):1951-7. PubMed ID: 2464495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The main obstacle to a malaria vaccine: the malaria parasite.
    Miller LH; Good MF
    Vaccine; 1988 Apr; 6(2):104-6. PubMed ID: 3291447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumsporozoite proteins of malaria parasites.
    Nussenzweig V; Nussenzweig RS
    Cell; 1985 Sep; 42(2):401-3. PubMed ID: 2411417
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.
    Ballou WR; Rothbard J; Wirtz RA; Gordon DM; Williams JS; Gore RW; Schneider I; Hollingdale MR; Beaudoin RL; Maloy WL
    Science; 1985 May; 228(4702):996-9. PubMed ID: 2988126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reacting antigens to Pc96, a protective antigen of Plasmodium chabaudi, in P. falciparum, P. vivax, and P. cynomolgi.
    Wanidworanun C; Barnwell JW; Nagasawa H; Aikawa M; Shear H
    Am J Trop Med Hyg; 1989 Jun; 40(6):579-84. PubMed ID: 2472747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular approaches to malaria vaccines.
    Godson GN
    Sci Am; 1985 May; 252(5):52-9. PubMed ID: 2408333
    [No Abstract]   [Full Text] [Related]  

  • 19. The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?
    Schofield L
    Bull World Health Organ; 1990; 68 Suppl(Suppl):66-73. PubMed ID: 1709835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
    Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT
    N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.